https://regulatorynews.com/circle-pharma-series-e-cid165-financing Regulatory News en 2026-09-21T09:37:33-04:00 Circle Pharma Raises $92.5M Series E for Cancer Drug https://regulatorynews.com/koning-health-breast-ct-tga-approval Regulatory News en 2026-09-21T09:37:33-04:00 Koning Health Wins TGA Approval for Breast CT System https://regulatorynews.com/sk-biopharmaceuticals-cenobamate-japan-approval Regulatory News en 2026-09-21T09:37:33-04:00 SK Biopharmaceuticals Completes Japan Epilepsy Approval https://regulatorynews.com/corcept-lifyorli-chmp-ovarian-cancer Regulatory News en 2026-09-21T05:58:17-04:00 CHMP Backs Corcept's Lifyorli for Ovarian Cancer https://regulatorynews.com/puretech-lyt200-mds-fast-track Regulatory News en 2026-09-21T05:58:17-04:00 FDA Grants Fast Track to PureTech's MDS Antibody https://regulatorynews.com/cyllene-eg110a-rmat-designation Regulatory News en 2026-09-20T09:33:47-04:00 Cyllene Wins FDA RMAT Status for Bladder Gene Therapy https://regulatorynews.com/sling-linsitinib-series-c-financing Regulatory News en 2026-09-20T09:33:47-04:00 Sling Nets $123M to Push Eye Drug Into Phase 3 https://regulatorynews.com/astrazeneca-klygefa-chmp-myasthenia-gravis Regulatory News en 2026-09-20T05:57:17-04:00 CHMP Backs AstraZeneca's Klygefa for Rare Disorder https://regulatorynews.com/fda-pma-estar-draft-guidance Regulatory News en 2026-09-20T05:57:17-04:00 FDA Drafts an eSTAR Template for Device PMAs https://regulatorynews.com/lilly-inluriyo-verzenio-esr1-breast-cancer Regulatory News en 2026-09-20T05:57:17-04:00 FDA Approves Lilly's Inluriyo-Verzenio Combo